Details

Autor(en) / Beteiligte

• Luis-Lima, Sergio
• Escamilla-Cabrera, Beatriz
• Negrín-Mena, Natalia
• Estupiñán, Sara
• Delgado-Mallén, Patricia
• Marrero-Miranda, Domingo
• González-Rinne, Ana
• Miquel-Rodríguez, Rosa
• Cobo-Caso, María Ángeles
• Hernández-Guerra, Manuel
• Oramas, Juana
• Batista, Norberto
• Aldea-Perona, Ana
• Jorge-Pérez, Pablo
• González-Alayón, Carlos
• Moreno-Sanfiel, Miguel
• González-Rodríguez, Juan Antonio
• Henríquez, Laura
• Alonso-Pescoso, Raquel
• Díaz-Martín, Laura
• González-Rinne, Federico
• Lavín-Gómez, Bernardo Alio
• Galindo-Hernández, Judith
• Sánchez-Gallego, Macarena
• González-Delgado, Alejandra
• Jiménez-Sosa, Alejandro
• Torres, Armando
• Porrini, Esteban

Titel

Chronic kidney disease staging with cystatin C or creatinine-based formulas: flipping the coin

Ist Teil von

• Nephrology, dialysis, transplantation, 2019-02, Vol.34 (2), p.287-294

Ort / Verlag

England: Oxford University Press

Erscheinungsjahr

2019

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Background Chronic kidney disease (CKD) affects 10–13% of the population worldwide. CKD classification stratifies patients in five stages of risk for progressive renal disease based on estimated glomerular filtration rate (eGFR) by formulas and albuminuria. However, the reliability of formulas to reflect real renal function is a matter of debate. The effect of the error of formulas in the CKD classification is unclear, particularly for cystatin C–based equations. Methods We evaluated the reliability of a large number of cystatin C and/or creatinine-based formulas in the definition of the stages of CKD in 882 subjects with different clinical situations over a wide range of glomerular filtration rates (GFRs) (4.2–173.7 mL/min). Results Misclassification was a constant for all 61 formulas evaluated and averaged 50% for creatinine-based and 35% for cystatin C–based equations. Most of the cases were misclassified as one stage higher or lower. However, in 10% of the subjects, one stage was skipped and patients were classified two stages above or below their real stage. No clinically relevant improvement was observed with cystatin C–based formulas compared with those based on creatinine. Conclusions The error in the classification of CKD stages by formulas was extremely common. Our study questions the reliability of both cystatin C and creatinine-based formulas to correctly classify CKD stages. Thus the correct classification of CKD stages based on estimated GFR is a matter of chance. This is a strong limitation in evaluating the severity of renal disease, the risk for progression and the evolution of renal dysfunction over time.